ArticleNature communications2024

Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.

Szymon J Szymura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.